1. Nugent RA, Fathima SF, Feigl AB, Chyung D: The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clinical practice 2011, 118(3):c269-277.
2. Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, Chen M, He Q, Liao Y, Yu X et al: Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 2012, 379(9818):815-822.
3. Chen XN, Pan XX, Yu HJ, Shen PY, Zhang QY, Zhang W, Ren H, Qian Y, Zhu P, Chen N: Analysis of cardiovascular disease in Chinese inpatients with chronic kidney disease. Internal medicine 2011, 50(17):1797-1801.
4. Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, Zhao MH, Lv J, Garg AX, Knight J et al: Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 2015, 385(9981):1975-1982.
5. Wang J, Zhang L, Tang SC, Kashihara N, Kim YS, Togtokh A, Yang CW, Zhao MH, North ISN, East Asia Regional B: Disease burden and challenges of chronic kidney disease in North and East Asia. Kidney international 2018, 94(1):22-25.
6. Ravani P, Palmer SC, Oliver MJ, Quinn RR, MacRae JM, Tai DJ, Pannu NI, Thomas C, Hemmelgarn BR, Craig JC et al: Associations between hemodialysis access type and clinical outcomes: a systematic review. Journal of the American Society of Nephrology : JASN 2013, 24(3):465-473.
7. Ravani P, Gillespie BW, Quinn RR, MacRae J, Manns B, Mendelssohn D, Tonelli M, Hemmelgarn B, James M, Pannu N et al: Temporal risk profile for infectious and noninfectious complications of hemodialysis access. Journal of the American Society of Nephrology : JASN 2013, 24(10):1668-1677.
8. Sato T, Sakurai H, Okubo K, Kusuta R, Onogi T, Tsuboi M: Current state of dialysis treatment and vascular access management in Japan. The journal of vascular access 2019, 20(1_suppl):10-14.
9. Kim YS, Kim Y, Shin SJ, Lee HS, Kim SG, Cho S, Na KR, Kim JK, Kim SJ, Kim YO et al: Current state of dialysis access management in Korea. The journal of vascular access 2019, 20(1_suppl):15-19.
10. Pisoni RL, Zepel L, Fluck R, Lok CE, Kawanishi H, Suleymanlar G, Wasse H, Tentori F, Zee J, Li Y et al: International Differences in the Location and Use of Arteriovenous Accesses Created for Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS). American journal of kidney diseases 2018, 71(4):469-478.
11. Bylsma LC, Gage SM, Reichert H, Dahl SLM, Lawson JH: Arteriovenous Fistulae for Haemodialysis: A Systematic Review and Meta-analysis of Efficacy and Safety Outcomes. European journal of vascular and endovascular surgery 2017, 54(4):513-522.
12. Robbin ML, Greene T, Allon M, Dember LM, Imrey PB, Cheung AK, Himmelfarb J, Huber TS, Kaufman JS, Radeva MK et al: Prediction of Arteriovenous Fistula Clinical Maturation from Postoperative Ultrasound Measurements: Findings from the Hemodialysis Fistula Maturation Study. Journal of the American Society of Nephrology : JASN 2018, 29(11):2735-2744.
13. Viecelli AK, Tong A, O'Lone E, Ju A, Hanson CS, Sautenet B, Craig JC, Manns B, Howell M, Chemla E et al: Report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop on Establishing a Core Outcome Measure for Hemodialysis Vascular Access. American journal of kidney diseases 2018, 71(5):690-700.
14. D'Agostino RB, Sr., Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB: General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008, 117(6):743-753.
15. Hsu YH, Yen YC, Lin YC, Sung LC: Correction: Antiplatelet agents maintain arteriovenous fistula and graft function in patients receiving hemodialysis: A nationwide case-control study. PloS one 2019, 14(4):e0215546.
16. Jankovic A, Damjanovic T, Djuric Z, Marinkovic J, Schlieper G, Tosic-Dragovic J, Djuric P, Popovic J, Floege J, Dimkovic N: Impact of vascular calcifications on arteriovenous fistula survival in hemodialysis patients: a five-year follow-up. Nephron 2015, 129(4):247-252.
17. Choi SJ, Yoon HE, Kim YS, Yoon SA, Yang CW, Kim YS, Park SC, Kim YO: Pre-existing Arterial Micro-Calcification Predicts Primary Unassisted Arteriovenous Fistula Failure in Incident Hemodialysis Patients. Seminars in dialysis 2015, 28(6):665-669.
18. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T et al: A new equation to estimate glomerular filtration rate. Annals of internal medicine 2009, 150(9):604-612.
19. Zhang Y, Kong X, Tang L, Wei Y, Xu D: Analysis of Follow-Up Methods of Vascular Access and Patient Outcomes in Hemodialysis at a Tertiary Care Hospital in China. Therapeutic apheresis and dialysis 2018, 22(2):160-165.
20. Cui J, Steele D, Wenger J, Kawai T, Liu F, Elias N, Watkins MT, Irani Z: Hemodialysis arteriovenous fistula as first option not necessary in elderly patients. Journal of vascular surgery 2016, 63(5):1326-1332.
21. Stracke S, Konner K, Kostlin I, Friedl R, Jehle PM, Hombach V, Keller F, Waltenberger J: Increased expression of TGF-beta1 and IGF-I in inflammatory stenotic lesions of hemodialysis fistulas. Kidney international 2002, 61(3):1011-1019.
22. Brahmbhatt A, Remuzzi A, Franzoni M, Misra S: The molecular mechanisms of hemodialysis vascular access failure. Kidney international 2016, 89(2):303-316.
23. Moon JY, Lee HM, Lee SH, Lee TW, Ihm CG, Jo YI, Han SW, Shin SG: Hyperphosphatemia is associated with patency loss of arteriovenous fistula after 1 year of hemodialysis. Kidney research and clinical practice 2015, 34(1):41-46.